diabetes
South Korea jails executives for their role in Samsung Biologics fraud
December 10, 2019Manufacturing and Production Samsung phones, Sanofi, Sanofi Diabetes, South Korea Healthcare System, South Korea Samsung, diabetes, inhaled insulin, insulin, south korea
Three executives of Samsung Electronics have been sentenced to jail for their role in committing fraud at its biotech affiliate …
FDA investigating if carcinogen NDMA is in diabetes drug
December 6, 2019Medical Communications FDA, Health Canada, MDMA, NDMA, carcinogen, diabetes
The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical. This comes after …
AstraZeneca’s Qtrilment scores European authorisation in type 2 diabetes
November 15, 2019Medical Communications, Sales and Marketing AstraZeneca, EU, Europe, Qtrilmet, diabetes, pharma, type 2 diabetes
Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) has secured approval in Europe, its manufacturer AstraZeneca has revealed, as a therapy to …
New report reveals shocking knowledge gaps around type 2 diabetes risk factors
November 14, 2019Medical Communications, Research and Development Merck KGaA, diabetes, pharma, type 2 diabetes
A new report released on World Diabetes Day has shone a light on a startling lack of knowledge surrounding type …
Promising Phase 3 data for Sanofi’s Toujeo secures CHMP recommendation of label expansion in type 1 diabetes
November 4, 2019Research and Development, Sales and Marketing EU, Sanofi, Type 1 diabetes, diabetes, pharma, toujeo
Sanofi took the opportunity at the International Society for Pediatric and Adolescent Diabetes 45th Annual Conference in Boston, Massachusetts to …
Novo’s Tresiba lowers hypoglycaemia risk compared to insulin glargine in type 2 diabetes
September 20, 2019Medical Communications, Research and Development Novo Nordisk, Tresiba, diabetes, pharma
Novo Nordisk has unveiled new data for Tresiba (insulin degludec) at the 55th Annual Meeting of the European Association for …
Sanofi’s Troujeo beats insulin degludec in head-to-head study in type 2 diabetes
September 19, 2019Research and Development Sanofi, Troujeo, diabetes, insulin degludec, pharma
Sanofi took the opportunity at the 55th annual European Association for the Study of Diabetes to present new data from …
Sanofi ends partnership with Lexicon after release of Phase 3 data
July 29, 2019Sales and Marketing Lexicon, Sanofi, Zynquista, diabetes, pharma
French firm Sanofi has said it is ending its partnership with Texas-based firm Lexicon Pharmaceuticals over the development of diabetes …
Lilly’s Baqsimi nasal powder gains FDA approval after proving non-inferior to injection
July 25, 2019Sales and Marketing Baqsimi, Eli Lilly, FDA, US, diabetes, pharma
Eli Lilly has been awarded approval from the FDA for its Baqsimi nasal powder in the treatment of severe hypoglycaemia, …
AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes
July 15, 2019Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …
FDA approves Novo Nordisk’s Victoza for children with type 2 diabetes
June 18, 2019Manufacturing and Production GLP-1, Novo Nordisk, Victoza, diabetes, liraglutide
The FDA has approved Novo Nordisk’s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes. …
Novo Nordisk’s oral diabetes drug safe and effective
June 12, 2019Research and Development GLP-1, Novo Nordisk, diabetes, pharma, samgalutide
Novo Nordisk’s oral diabetes drug semaglutide is safe for those at high risk of cardiovascular complications, according to the results …
AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes
June 11, 2019Manufacturing and Production, Research and Development AstraZeneca, diabetes, farxiga, pharma, type 2 diabetes
AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on …
Sanofi’s Soliqua proves superior to GLP-1 RA therapies in reducing blood sugar levels
June 10, 2019Research and Development, Sales and Marketing Sanofi, Soliqua, diabetes, pharma, type 2 diabetes
Sanofi has stepped up at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, revealing new data which …
Novo’s oral semaglutide tops Jardiance and Victoza in two type 2 diabetes trials
June 10, 2019Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has taken the opportunity at the American Diabetes Association (ADA) 79th Scientific Sessions to pull back the curtain …
Latest content
